Formex LLC is a leading contract development and manufacturing organization focusing on oral and topical dosage forms.

Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion and spray drying.

Formex provides pre-formulation, formulation development, analytical method development, analytical testing, pre-clinical manufacturing, cGMP clinical trial manufacturing for Phase 0-IIb & small scale cytotoxic and high potent compound manufacturing.

Formex is a wholly-owned subsidiary of the Biotech Investment Group (BIG). BIG, founded in 2006, is a provider of growth equity capital to emerging healthcare services companies. BIG’s mission is to partner with outstanding entrepreneurs to build long-lasting companies and deliver services which address significant unmet healthcare needs.

Formex currently operates in 40,000 sq. ft. of a 80,000 sq. ft. facility in Torrey Pines, California. The California Health Department qualified facility includes 20,000 sq. ft. of cGMP manufacturing space allocated among 10 separate suites. Two suites are dedicated to Cytotoxic and High Potent Compound R&D and cGMP Manufacturing. The facility also houses R&D, Formulation Analytical Labs, and 2,000 sq. ft. of temperature controlled warehouse space.

Want to work with the Formulation Experts?

See how Formex can help solve your formulation problems

Contact us today